{"text": "Inhibition of <extra_id_0> cyclooxygenase-2 <extra_id_2> Protein <extra_id_1> expression by 4-trifluoromethyl derivatives of salicylate , triflusal , and its deacetylated metabolite , 2-hydroxy-4-trifluoromethylbenzoic acid .", "event": "<extra_id_0> <extra_id_0> Negative_regulation Inhibition <extra_id_0> Theme expression <extra_id_1> <extra_id_1> <extra_id_0> Gene_expression expression <extra_id_0> Theme cyclooxygenase-2 <extra_id_1> <extra_id_1> <extra_id_1>"}
{"text": "The therapeutic potential of drugs that block the induction of <extra_id_0> cyclooxygenase-2 <extra_id_2> Protein <extra_id_1> has been emphasized .", "event": "<extra_id_0> <extra_id_1>"}
{"text": "When two 4-trifluoromethyl salicylate derivatives [ 2-acetoxy-4-trifluoromethyl-benzoic acid ( triflusal ) and its deacetylated metabolite 2-hydroxy-4-trifluoromethylbenzoic acid ( HTB ) ] were compared with aspirin and sodium salicylate as <extra_id_0> cyclooxygenase-2 <extra_id_2> Protein <extra_id_1> ( <extra_id_0> COX-2 <extra_id_2> Protein <extra_id_1> ) inhibitors , we observed that in bacterial lipopolysaccharide - activated human blood , triflusal , aspirin , and HTB , but not sodium salicylate , inhibited <extra_id_0> COX-2 <extra_id_2> Protein <extra_id_1> - mediated prostaglandin E2 ( PGE2 ) production ( IC50 = 0.16 , 0.18 , 0.39 , and > 10 mM , respectively ) .", "event": "<extra_id_0> <extra_id_1>"}
{"text": "However , only triflusal and aspirin inhibited purified <extra_id_0> COX-2 <extra_id_2> Protein <extra_id_1> enzyme .", "event": "<extra_id_0> <extra_id_0> Negative_regulation inhibited <extra_id_0> Theme COX-2 <extra_id_1> <extra_id_1> <extra_id_1>"}
{"text": "To test this apparent discrepancy , we realized that HTB and triflusal ( but neither aspirin nor salicylate ) produced a concentration - dependent inhibition of <extra_id_0> COX-2 <extra_id_2> Protein <extra_id_1> protein expression in peripheral human mononuclear cells .", "event": "<extra_id_0> <extra_id_0> Positive_regulation produced <extra_id_0> Theme inhibition <extra_id_1> <extra_id_1> <extra_id_0> Negative_regulation inhibition <extra_id_0> Theme expression <extra_id_1> <extra_id_1> <extra_id_0> Gene_expression expression <extra_id_0> Theme COX-2 <extra_id_1> <extra_id_1> <extra_id_1>"}
{"text": "This observation was further confirmed in a rat air pouch model in vivo , in which both aspirin and triflusal inhibited PGE2 production ( ID50 = 18.9 and 11.4 mg / kg p.o . , respectively ) but only triflusal - treated animals showed a decrease in <extra_id_0> COX-2 <extra_id_2> Protein <extra_id_1> expression .", "event": "<extra_id_0> <extra_id_0> Negative_regulation decrease <extra_id_0> Theme expression <extra_id_1> <extra_id_1> <extra_id_0> Gene_expression expression <extra_id_0> Theme COX-2 <extra_id_1> <extra_id_1> <extra_id_1>"}
{"text": "This different behavior may be , at least in part , due to the ability of HTB and triflusal to block the activation of the transcription factor nuclear factor-kappaB to a higher extent than aspirin and sodium salicylate .", "event": "<extra_id_0> <extra_id_1>"}
{"text": "Thus , in addition to inhibiting the <extra_id_0> COX-2 <extra_id_2> Protein <extra_id_1> activity at therapeutic concentrations , triflusal is able to block through its metabolite HTB the expression of new enzyme , and hence the resumption of PGE2 synthesis .", "event": "<extra_id_0> <extra_id_0> Negative_regulation block <extra_id_1> <extra_id_0> Gene_expression expression <extra_id_1> <extra_id_1>"}
{"text": "Triflusal and HTB may exert beneficial effects in processes in which de novo <extra_id_0> COX-2 <extra_id_2> Protein <extra_id_1> expression is involved and , in a broader sense , in pathological situations in which genes under nuclear factor-kappaB control are up-regulated .", "event": "<extra_id_0> <extra_id_0> Gene_expression expression <extra_id_0> Theme COX-2 <extra_id_1> <extra_id_1> <extra_id_1>"}
